Literature DB >> 7817381

UN1, a murine monoclonal antibody recognizing a novel human thymic antigen.

P Tassone1, H Bond, P Bonelli, F Tuccillo, G Valerio, A Petrella, A Lamberti, L Cecco, M C Turco, M Cerra.   

Abstract

A murine monoclonal antibody (mAb) UN1 was produced on the basis of selective reactivity with human thymocytes. Characterization of UN1 by immunofluorescence gave a high intensity of labeling with the majority of human thymocytes. Expression was preferentially associated with immature thymocytes (CD3dim) compared to mature cells, whereas only a subpopulation of peripheral blood lymphocytes was weakly stained. No specific binding to monocytes or granulocytes was detected. The T-cell lines HPB-ALL, H9 and MOLT-4 were all positively bound by UN1. Immunohistological staining of thymic tissues showed that mAb UN1 detected cells in both the cortex and medulla of fetal thymus, whereas the reaction in thymus samples from young children was mainly with medullar cells. By western blotting analysis, the antigen recognized by mAb UN1 corresponds to a membrane polypeptide with a molecular weight of approximately 120 kDa present on thymocytes and HPB-ALL cells. The mAb UN1 was submitted to the 5th International Workshop and Conference on Human Leukocyte Differentiation Antigens, Boston, 1993. UN1 did not cluster in any of the old or new clusters of differentiation discussed at the conference, indicating its unique reactivity. Together with the data presented in this paper, this suggests that the UN1 antibody defines a previously undescribed molecule present on the cell surface of thymocytes and a minority of peripheral blood lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7817381     DOI: 10.1111/j.1399-0039.1994.tb02362.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Cancer-associated CD43 glycoforms as target of immunotherapy.

Authors:  Franca Maria Tuccillo; Camillo Palmieri; Giuseppe Fiume; Annamaria de Laurentiis; Marco Schiavone; Cristina Falcone; Enrico Iaccino; Ricciarda Galandrini; Cristina Capuano; Angela Santoni; Francesco Paolo D'Armiento; Claudio Arra; Antonio Barbieri; Fabrizio Dal Piaz; David Venzon; Patrizia Bonelli; Franco Maria Buonaguro; Iris Scala; Massimo Mallardo; Ileana Quinto; Giuseppe Scala
Journal:  Mol Cancer Ther       Date:  2013-12-19       Impact factor: 6.261

2.  Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.

Authors:  Annamaria de Laurentiis; Marco Gaspari; Camillo Palmieri; Cristina Falcone; Enrico Iaccino; Giuseppe Fiume; Ornella Massa; Mariorosario Masullo; Franca Maria Tuccillo; Laura Roveda; Ubaldo Prati; Olga Fierro; Immacolata Cozzolino; Giancarlo Troncone; Pierfrancesco Tassone; Giuseppe Scala; Ileana Quinto
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

3.  A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.

Authors:  Catharina Steentoft; Max Fuhrmann; Federico Battisti; Julie Van Coillie; Thomas D Madsen; Diana Campos; Adnan Halim; Sergey Y Vakhrushev; Hiren J Joshi; Hans Schreiber; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-04-01       Impact factor: 4.313

Review 4.  CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?

Authors:  Pooria Safarzadeh Kozani; Pouya Safarzadeh Kozani; Fatemeh Rahbarizadeh
Journal:  Front Med       Date:  2022-06-10       Impact factor: 9.927

Review 5.  Aberrant glycosylation as biomarker for cancer: focus on CD43.

Authors:  Franca Maria Tuccillo; Annamaria de Laurentiis; Camillo Palmieri; Giuseppe Fiume; Patrizia Bonelli; Antonella Borrelli; Pierfrancesco Tassone; Iris Scala; Franco Maria Buonaguro; Ileana Quinto; Giuseppe Scala
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

6.  Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.

Authors:  Daniele Caracciolo; Caterina Riillo; Andrea Ballerini; Giuseppe Gaipa; Ludovic Lhermitte; Marco Rossi; Cirino Botta; Eugénie Duroyon; Katia Grillone; Maria Eugenia Gallo Cantafio; Chiara Buracchi; Greta Alampi; Alessandro Gulino; Beatrice Belmonte; Francesco Conforti; Gaetanina Golino; Giada Juli; Emanuela Altomare; Nicoletta Polerà; Francesca Scionti; Mariamena Arbitrio; Michelangelo Iannone; Massimo Martino; Pierpaolo Correale; Gabriella Talarico; Andrea Ghelli Luserna di Rorà; Anna Ferrari; Daniela Concolino; Simona Sestito; Licia Pensabene; Antonio Giordano; Markus Hildinger; Maria Teresa Di Martino; Giovanni Martinelli; Claudio Tripodo; Vahid Asnafi; Andrea Biondi; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.